Personalised nutrition specialist to “improve the health of millions” via £73m investment

ZOE, the London based, personalised nutrition company that runs the world’s largest nutrition-science study and the ZOE Health Study, has announced that it has secured £25m via its Series B extension round.

The funds will be used to rapidly scale operations in the UK to enable ZOE to meet the demand of its 250,000-strong waitlist and expand its research as it works to “improve the health of millions”.

This latest funding round comes from ZOE’s existing international investors, led by Accomplice, with investment from Balderton Capital, Ahren, Daphni, and new investor L Catterton, and brings ZOE’s total investment to £73m.

In 2022, ZOE has launched its personalised nutrition programme in the UK, quadrupled monthly sales, hired over 100 employees, reached a waitlist of 250,000 people, and launched the UK’s number one nutrition podcast, ZOE Science and Nutrition podcast.

The company’s valuation has increased since its last round of funding despite the “tough economic environment”. Rather than including more institutional investors in this round, ZOE plans to build on this success by inviting its community of over two million to invest via Crowdcube.

ZOE is opening this opportunity to its community because it believes it can “build even better science with members more deeply participating in its journey” and because it wishes members to “share in the company’s future success”.

The ZOE community will have exclusive access to participate on December 13, followed by the Crowdcube community starting on December 14 before launching to the public. Anyone in the UK and EU can invest and become an owner for as little as £10, at the same share price as ZOE’s private investors in the latest round.

George Hadjigeorgiou, co-founder and President of ZOE, commented: “Five years ago we set out to get people to think differently about their health and we knew we had to start with real science. For us, our community has made all the difference.

“It started with the participants of our PREDICT studies, and grew thanks to millions of people who contributed to the ZOE COVID Study and it now includes the tens of thousands of ZOE members, who are seeing life changing improvements. Every single one of them has helped us to deliver new science, insights and advice and a healthier future.

“With the latest funding, and inviting our incredible ZOE community to invest and become owners too - we will be able to bring ZOE to more people faster. We’ll invest more in what makes us so unique, our science, and offer even more personalised insights, advice and services to members.”

By Matthew Neville – Correspondent, Bdaily

• Add me on LinkedIn and Twitter to keep up to date
• And follow Bdaily on Facebook, Twitter and LinkedIn
• Submit press releases to editor@bdaily.co.uk for consideration.